NFKB1 and neoplasm: Tumor-derived MDSCs activate the PI3K/AKT/NF-κB pathway in B cells by a direct receptor-ligand interaction, and MDSC-educated PD-1−PD-L1+ Bregs suppress the T cell immune response, thereby contributing to tumor progression.